Loading...

Course Description

This session will describe the staging tests commonly used in canine lymphoma. We will highlight the importance of phenotyping and the various tests to determine phenotype. We will discuss standard of care chemotherapy with an emphasis of the new conditionally approved drug, Laverdia CA-1, its mechanism of action, data to support its use and where I see the drug being utilized.

Benefits to the Learner

  • Understand the importance of phenotyping canine lymphoma
  • Define and understand the role of SINE inhibitors
  • Discuss the new conditionally approved Laverdia CA-1

Accrediting Associations

Loading...
Thank you for your interest in this course. Unfortunately, the course you have selected is currently not open for enrollment. Please complete a Course Inquiry so that we may promptly notify you when enrollment opens.
Required fields are indicated by .